Valsartan tablets USP 320 mg, 90-count bottles recall — FDA D-0370-2019
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level…